References
- http://texnat.tamu.edu/cmplants/toxic/text/AFRICAN.htm Hart C, Carpenter B, Reager J, McGinty A. Texas Natural Resource Server Toxic Plant Database. (31 January 2007).
- http://www.unce.unr.edu/publications/FS01/FS0145.pdf Davison J, Wargo M. University of Nevada, Cooperative Extension, Publications Page 31 May 2005, (31 January 2007).
- http://plants.usda.gov/plants USDA, NRCS. The Plants Database, 1999, (31 January 2007).
- http://www.erowid.org/plants/syrian_rue/syrian_rue_info4.pdf Anonymous. An Indo-European Plant-Teacher, 1986 Gracie and Zarkov Productions, (5 February 2007).
- M Mahmoudian, and P Jalilpour, Salehian. (2002). Toxicity of Peganum harmala: review and a case report. Iranian J Pharm Therap 1:1–4.
- NB Salah, M Amamou, Z Jerbi, FB Salah, and M Yacoub. (1986). A case of overdose with Peganum harmala. J Toxicol Clin Exp 6:319–322.
- Q Chen, R Chao, H Chen, X Hou, H Yan, S Zhou, W Peng, and A Xu. (2005). Antitumor and neurotoxic effects of novel harmine derivates and structure-activity relationship analysis. Int J Cancer 114:675–682.
- F Lamchouri, A Settaf, Y Cherrah, M El Hamidi, N Tligui, B Lyoussi, and M Hasar. (2002). Experimental toxicity of Peganum harmala seeds. Ann Pharm Fr 60:123–129.
- F Lamchouri, A Settaf, Y Cherrah, M Hasar, M Zemzami, N Atif, FB Nadori, A Zaid, and B Lyoussi. (2000). In vitro cell-toxicity of Peganum harmala alkoloids on cancerous cell-lines. Fitoterapia 71:50–54.
- J Riba, M Valle, G Urbano, M Yritia, A Morte, and MJ Barbanoj. (2003). Human Pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol and Exp Ther 306 (1):73–83.
- http://www.drugtext.org/library/books/recreationaldrugs/syrianrue.htm Young LA, Young LG, Klein MM, Klein DM, Beyer D. Recreational Drugs: Everything you need to know about the drugs people take for pleasure today, 20 January 2004, (31 January 2007).
- M El-Saad El-Rifaie. (1980). Peganum harmala: its use in certain dermatoses. Int J Dermatol 19:221–222.
- DE Brush, S Bird, and EW Boyer. (2004). Monoamine oxidase inhibitor poisoning resulting from internet misinformation on illicit substances. J Toxicol Clin Toxicol 42:191–195.
- L Kokan. Monoamine oxidase inhibitorsToxicologic Emergencies. 7thLR Goldfrank, NE Flomenboum, and NA Lewin. McGraw-Hill, New YorkUSA, (2002)885–893.
- A Yu, JR Idle, KW Krausz, A Kupfer, and FJ Gonzales. (2003). Contribution of individual cytochrome P450 isozymes to the o-demethylation of the psychotropic β-carboline alkaloids harmaline and harmine. J Pharmacol and Exp Ther 305 (1):315–322.
- TA Slotkin, V DiStefano, and WY Au. (1970). Blood levels and urinary excretion of harmine and its metabolites in man and rats. J Pharmacol and Exp Ther 173:23–30.
- RA Glennon, M Dukat, B Grella, S Hong, L Costantino, M Teitler, C Smith, C Egan, K Davis, and MV Mattson. (2000). Binding beta carbolines and related agents at serotonin (5HT (2) and 5HT(1A)), dopamine (D(2)) and benzodiazepine receptors. Drug Alcohol Depend 60:121–132.
- J Lutes, JF Lorden, M Beales, and GA Oltmans. (1988). Tolerance to the tremorogenic effects of harmaline: evidence for altered olivo-cerebellar function. Neuropharmacology 27:849–855.
- SM Husbands, RA Glennon, S Gorgerat, R Gough, R Tyacke, J Crosby, DJ Nutt, JW Lewis, and AL Hudson. (2001). Beta-carboline binding to imidazoline receptors. Drug alcohol depend 64:203–208.
- E Ruiz-Durantez, JA Ruiz-Ortega, J Pineda, and L Ugedo. (2001). Stimulatory effect of harmane and other β-carbolines on locus coeruleus neurons in anaesthetized rats. Neurosci Lett 308:197–200.
- M Iurlo, G Leone, B Schilstrom, L Linner, G Nomikos, P Hertel, B Silvestrini, and H Svensson. (2001). Effects of harmine on dopamine output and metabolism in rat striatum: Role of monoamine oxidase-A inhibition. Psychopharmacology 159:98–104.
- C Hamouda, M Amamou, H Thabet, M Yacoub, A Hedhili, F Bescharnia, N Ben Salah, M Zhioua, S Abdelmoumen, and N El Mekki Ben Brahim. (2000). Plant poisonings from herbal medication admitted to a Tunisian toxicologic intensive care unit, 1983–1998. Vet Hum Toxicol 42:137–141.